Pfizer (PFE) Moves One Step Closer to Split as CEO Read Mulls Idea
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/16/2024
- Wall Street stocks close lower on higher Treasury yields, rate expectations
- Powell says recent inflation data point to need to keep rates higher for longer
- United Airlines maintains forecast after Q1 results top Wall Street estimates
- UnitedHealth (UNH) beats earnings, revenue estimates in Q1; shares up
- Bank of America profit hurt by losses on credit cards, office loans
- Trump Media & Technology Group (DJT) Files S-1
- Tesla (TSLA) Senior VP Drew Baglino Is Said To Leave The Company - Bloomberg
- GE HealthCare (GEHC) Announces Resignation of Jan Makela, CEO of Imaging
- General Motors (GM) Said to be Moving Detroit HQ to Dan Gilbert's Hudson Tower - Bloomberg
- Biohaven Pharma (BHVN) presents update on degrader platform and summary of progress to date in Phase 1 single ascending dose study for BHV-1300
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
- After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more
- Midday movers: Goldman Sachs and Meta Platforms rise; Apple and Tesla fall
Pfizer, Inc. (PFE) Tops Q4 EPS by 3c; Guides In-Line
January 29, 2013 7:01 AM ESTPfizer, Inc. (NYSE: PFE) reported Q4 EPS of $0.47, $0.03 better than the analyst estimate of $0.44. Revenue for the quarter came in at $15.1 billion versus the consensus estimate of $14.4 billion.
Pfizer, Inc. sees FY2013 EPS of $2.20-2.30, versus the consensus of $2.29. Pfizer, Inc. sees FY2013... More
